# Amphenol Corp: financial statements, quarterly

APH · NYSE · CIK 820313 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aph.md) · [Financials](/companies/aph/financials.md) · [Filings](/companies/aph/filings.md) · [Insiders](/companies/aph/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aph/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,199](/filings/0001558370-24-013696.md) | [3,328 d](/filings/0001104659-26-013549.md) | [3,256](/filings/0001558370-25-005558.md) | [3,610](/filings/0001558370-25-009610.md) | [4,039](/filings/0001104659-25-102142.md) | [4,318 d](/filings/0001104659-26-013549.md) | [4,811](/filings/0001104659-26-054128.md) | [5,650](/filings/0001104659-26-089194.md) | [6,194](/filings/0001104659-25-102142.md) | [6,439 d](/filings/0001104659-26-013549.md) | [7,620](/filings/0001104659-26-054128.md) | [8,758](/filings/0001104659-26-089194.md) |
| Cost of revenue | $m | [2,151](/filings/0001558370-24-013696.md) | [2,227 d](/filings/0001104659-26-013549.md) | [2,167](/filings/0001558370-25-005558.md) | [2,397](/filings/0001558370-25-009610.md) | [2,682](/filings/0001104659-25-102142.md) | [2,837 d](/filings/0001104659-26-013549.md) | [3,167](/filings/0001104659-26-054128.md) | [3,597](/filings/0001104659-26-089194.md) | [3,835](/filings/0001104659-25-102142.md) | [3,978 d](/filings/0001104659-26-013549.md) | [4,820](/filings/0001104659-26-054128.md) | [5,210](/filings/0001104659-26-089194.md) |
| Gross profit | $m | [1,049](/filings/0001558370-24-013696.md) | [1,100 d](/filings/0001104659-26-013549.md) | [1,089](/filings/0001558370-25-005558.md) | [1,213](/filings/0001558370-25-009610.md) | [1,357](/filings/0001104659-25-102142.md) | [1,481 d](/filings/0001104659-26-013549.md) | [1,644](/filings/0001104659-26-054128.md) | [2,053](/filings/0001104659-26-089194.md) | [2,359](/filings/0001104659-25-102142.md) | [2,461 d](/filings/0001104659-26-013549.md) | [2,800](/filings/0001104659-26-054128.md) | [3,548](/filings/0001104659-26-089194.md) |
| Selling, general and administrative | $m | [382](/filings/0001558370-24-013696.md) | [394 d](/filings/0001104659-26-013549.md) | [404](/filings/0001558370-25-005558.md) | [444](/filings/0001558370-25-009610.md) | [492](/filings/0001104659-25-102142.md) | [515 d](/filings/0001104659-26-013549.md) | [575](/filings/0001104659-26-054128.md) | [623](/filings/0001104659-26-089194.md) | [657](/filings/0001104659-25-102142.md) | [691 d](/filings/0001104659-26-013549.md) | [852](/filings/0001104659-26-054128.md) | [940](/filings/0001104659-26-089194.md) |
| Operating income | $m | [658](/filings/0001558370-24-013696.md) | [690 d](/filings/0001104659-26-013549.md) | [685](/filings/0001558370-25-005558.md) | [699](/filings/0001558370-25-009610.md) | [820](/filings/0001104659-25-102142.md) | [954 d](/filings/0001104659-26-013549.md) | [1,025](/filings/0001104659-26-054128.md) | [1,419](/filings/0001104659-26-089194.md) | [1,702](/filings/0001104659-25-102142.md) | [1,723 d](/filings/0001104659-26-013549.md) | [1,832](/filings/0001104659-26-054128.md) | [2,585](/filings/0001104659-26-089194.md) |
| Interest expense | $m | [33.6](/filings/0001558370-23-016952.md) | [35.0 d](/filings/0001558370-24-000866.md) | [38.1](/filings/0001558370-24-005928.md) | [56.3](/filings/0001558370-25-009610.md) | [55.7](/filings/0001104659-25-102142.md) | [66.9 d](/filings/0001104659-26-013549.md) | [76.5](/filings/0001104659-26-054128.md) | [80.9](/filings/0001104659-26-089194.md) | [80.7](/filings/0001104659-25-102142.md) | [130 d](/filings/0001104659-26-013549.md) | [208](/filings/0001104659-26-054128.md) | [214](/filings/0001104659-26-089194.md) |
| Income tax | $m | [115](/filings/0001558370-24-013696.md) | [146 d](/filings/0001104659-26-013549.md) | [111](/filings/0001558370-25-005558.md) | [135](/filings/0001558370-25-009610.md) | [166](/filings/0001104659-25-102142.md) | [158 d](/filings/0001104659-26-013549.md) | [219](/filings/0001104659-26-054128.md) | [247](/filings/0001104659-26-089194.md) | [386](/filings/0001104659-25-102142.md) | [444 d](/filings/0001104659-26-013549.md) | [702](/filings/0001104659-26-054128.md) | [604](/filings/0001104659-26-089194.md) |
| Net income | $m | [514](/filings/0001558370-24-013696.md) | [514 d](/filings/0001104659-26-013549.md) | [549](/filings/0001558370-25-005558.md) | [525](/filings/0001558370-25-009610.md) | [604](/filings/0001104659-25-102142.md) | [746 d](/filings/0001104659-26-013549.md) | [738](/filings/0001104659-26-054128.md) | [1,091](/filings/0001104659-26-089194.md) | [1,246](/filings/0001104659-25-102142.md) | [1,196 d](/filings/0001104659-26-013549.md) | [933](/filings/0001104659-26-054128.md) | [1,769](/filings/0001104659-26-089194.md) |
| Diluted EPS | $ per share | [0.41](/filings/0001558370-24-013696.md) | not reported | [0.44](/filings/0001558370-25-005558.md) | [0.41](/filings/0001558370-25-009610.md) | [0.48](/filings/0001104659-25-102142.md) | not reported | [0.58](/filings/0001104659-26-054128.md) | [0.86](/filings/0001104659-26-089194.md) | [0.97](/filings/0001104659-25-102142.md) | not reported | [0.72](/filings/0001104659-26-054128.md) | [1.37](/filings/0001104659-26-089194.md) |
| Basic EPS | $ per share | [0.43](/filings/0001558370-24-013696.md) | not reported | [0.46](/filings/0001558370-25-005558.md) | [0.44](/filings/0001558370-25-009610.md) | [0.50](/filings/0001104659-25-102142.md) | not reported | [0.61](/filings/0001104659-26-054128.md) | [0.90](/filings/0001104659-26-089194.md) | [1.02](/filings/0001104659-25-102142.md) | not reported | [0.76](/filings/0001104659-26-054128.md) | [1.44](/filings/0001104659-26-089194.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.5](/filings/0001558370-23-016952.md) | [1.5](/filings/0001558370-25-000714.md) | [1.9](/filings/0001558370-24-005928.md) | [1.3](/filings/0001558370-24-010246.md) | [1.6](/filings/0001558370-24-013696.md) | [3.3](/filings/0001104659-26-013549.md) | [1.7](/filings/0001558370-25-005558.md) | [3.2](/filings/0001558370-25-009610.md) | [3.8](/filings/0001104659-25-102142.md) | [11.1](/filings/0001104659-26-089194.md) | [4.1](/filings/0001104659-26-054128.md) | [4.7](/filings/0001104659-26-089194.md) |
| Current assets | $bn | [6.8](/filings/0001558370-23-016952.md) | [6.8](/filings/0001558370-25-000714.md) | [7.0](/filings/0001558370-24-005928.md) | [7.0](/filings/0001558370-24-010246.md) | [7.8](/filings/0001558370-24-013696.md) | [9.7](/filings/0001104659-26-013549.md) | [9.1](/filings/0001558370-25-005558.md) | [11.3](/filings/0001558370-25-009610.md) | [12.4](/filings/0001104659-25-102142.md) | [20.3](/filings/0001104659-26-089194.md) | [15.4](/filings/0001104659-26-054128.md) | [17.8](/filings/0001104659-26-089194.md) |
| Total assets | $bn | [15.8](/filings/0001558370-23-016952.md) | [16.5](/filings/0001558370-25-000714.md) | [16.7](/filings/0001558370-24-005928.md) | [18.6](/filings/0001558370-24-010246.md) | [19.6](/filings/0001558370-24-013696.md) | [21.4](/filings/0001104659-26-013549.md) | [22.9](/filings/0001558370-25-005558.md) | [25.7](/filings/0001558370-25-009610.md) | [27.1](/filings/0001104659-25-102142.md) | [36.2](/filings/0001104659-26-089194.md) | [42.1](/filings/0001104659-26-054128.md) | [44.8](/filings/0001104659-26-089194.md) |
| Current liabilities | $bn | [2.9](/filings/0001558370-23-016952.md) | [3.2](/filings/0001558370-25-000714.md) | [3.4](/filings/0001558370-24-005928.md) | [3.5](/filings/0001558370-24-010246.md) | [3.9](/filings/0001558370-24-013696.md) | [4.1](/filings/0001104659-26-013549.md) | [4.6](/filings/0001558370-25-005558.md) | [5.6](/filings/0001558370-25-009610.md) | [6.0](/filings/0001104659-25-102142.md) | [6.8](/filings/0001104659-26-089194.md) | [9.0](/filings/0001104659-26-054128.md) | [9.4](/filings/0001104659-26-089194.md) |
| Total liabilities | $bn | [7.8](/filings/0001558370-23-016952.md) | [8.1](/filings/0001558370-25-000714.md) | [8.0](/filings/0001558370-24-005928.md) | [9.5](/filings/0001558370-24-010246.md) | [10.1](/filings/0001558370-24-013696.md) | [11.6](/filings/0001104659-26-013549.md) | [12.5](/filings/0001558370-25-005558.md) | [14.1](/filings/0001558370-25-009610.md) | [14.5](/filings/0001104659-25-102142.md) | [22.7](/filings/0001104659-26-089194.md) | [28.0](/filings/0001104659-26-054128.md) | [29.2](/filings/0001104659-26-089194.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [7.9](/filings/0001558370-23-016952.md) | [8.3](/filings/0001558370-25-000714.md) | [8.7](/filings/0001558370-24-005928.md) | [9.0](/filings/0001558370-24-010246.md) | [9.5](/filings/0001558370-24-013696.md) | [9.8](/filings/0001104659-26-013549.md) | [10.3](/filings/0001558370-25-005558.md) | [11.5](/filings/0001558370-25-009610.md) | [12.5](/filings/0001104659-25-102142.md) | [13.4](/filings/0001104659-26-089194.md) | [14.0](/filings/0001104659-26-054128.md) | [15.5](/filings/0001104659-26-089194.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [618 d](/filings/0001558370-24-013696.md) | [842 d](/filings/0001104659-26-013549.md) | [600](/filings/0001558370-25-005558.md) | [664 d](/filings/0001558370-25-009610.md) | [704 d](/filings/0001104659-25-102142.md) | [847 d](/filings/0001104659-26-013549.md) | [765](/filings/0001104659-26-054128.md) | [1,417 d](/filings/0001104659-26-089194.md) | [1,471 d](/filings/0001104659-25-102142.md) | [1,722 d](/filings/0001104659-26-013549.md) | [1,122](/filings/0001104659-26-054128.md) | [1,557 d](/filings/0001104659-26-089194.md) |
| Capital expenditure | $m | [74.7 d](/filings/0001558370-24-013696.md) | [105 d](/filings/0001104659-26-013549.md) | [94.3](/filings/0001558370-25-005558.md) | [141 d](/filings/0001558370-25-009610.md) | [230 d](/filings/0001104659-25-102142.md) | [200 d](/filings/0001104659-26-013549.md) | [189](/filings/0001104659-26-054128.md) | [297 d](/filings/0001104659-26-089194.md) | [257 d](/filings/0001104659-25-102142.md) | [254 d](/filings/0001104659-26-013549.md) | [292](/filings/0001104659-26-054128.md) | [356 d](/filings/0001104659-26-089194.md) |
| Dividends paid | $m | [125](/filings/0001558370-24-013696.md) | [126 d](/filings/0001104659-26-013549.md) | [132](/filings/0001558370-25-005558.md) | [132](/filings/0001558370-25-009610.md) | [132](/filings/0001104659-25-102142.md) | [199 d](/filings/0001104659-26-013549.md) | [200](/filings/0001104659-26-054128.md) | [200](/filings/0001104659-26-089194.md) | [201](/filings/0001104659-25-102142.md) | [202 d](/filings/0001104659-26-013549.md) | [307](/filings/0001104659-26-054128.md) | [307](/filings/0001104659-26-089194.md) |
| Share repurchases | $m | [149 d](/filings/0001558370-24-013696.md) | [115 d](/filings/0001104659-26-013549.md) | [154](/filings/0001558370-25-005558.md) | [190 d](/filings/0001558370-25-009610.md) | [176 d](/filings/0001104659-25-102142.md) | [169 d](/filings/0001104659-26-013549.md) | [181](/filings/0001104659-26-054128.md) | [160 d](/filings/0001104659-26-089194.md) | [153 d](/filings/0001104659-25-102142.md) | [171 d](/filings/0001104659-26-013549.md) | [178](/filings/0001104659-26-054128.md) | [208 d](/filings/0001104659-26-089194.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [619](/filings/0001558370-23-016952.md) | [620](/filings/0001558370-24-005928.md) | [1,237](/filings/0001558370-24-010246.md) | [1,244](/filings/0001558370-24-013696.md) | [1,256](/filings/0001558370-25-005558.md) | [1,265](/filings/0001558370-25-009610.md) | [1,266](/filings/0001104659-25-102142.md) | [1,266](/filings/0001104659-26-054128.md) | [1,272](/filings/0001104659-26-089194.md) | [1,283](/filings/0001104659-25-102142.md) | [1,290](/filings/0001104659-26-054128.md) | [1,289](/filings/0001104659-26-089194.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,232,983,457 at 2026-07-28, from the cover of the [10-Q filed 2026-07-31](/filings/0001104659-26-089194.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.